Genetic alterations harboring MYC are common in RCC with focal amplifications of MYC-harboring regions validated in ccRCC37,38, although the role of MYC in RCC pathogenesis itself is complex with HIF2α and HIF1α playing opposing roles in modulating MYC transcriptional activity39,40. Here, EPAS1 is linked to renal cell carcinoma.